Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.660
-0.020 (-1.19%)
Nov 20, 2024, 4:00 PM EST - Market closed

Cerus Revenue

Cerus had revenue of $46.02M in the quarter ending September 30, 2024, with 15.70% growth. This brings the company's revenue in the last twelve months to $176.23M, up 14.71% year-over-year. In the year 2023, Cerus had annual revenue of $156.37M, down -3.51%.

Revenue (ttm)
$176.23M
Revenue Growth
+14.71%
P/S Ratio
1.73
Revenue / Employee
$276,655
Employees
637
Market Cap
308.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023156.37M-5.68M-3.51%
Dec 31, 2022162.05M31.19M23.83%
Dec 31, 2021130.86M38.94M42.36%
Dec 31, 202091.92M17.27M23.14%
Dec 31, 201974.65M13.74M22.56%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Spok Holdings 137.71M
Sanara MedTech 78.06M
Delcath Systems 22.64M
Nyxoah 5.67M
Lexicon Pharmaceuticals 5.23M
Absci 4.21M
Immutep 2.56M
Lyell Immunopharma 63.00K
Revenue Rankings